Our data has shown that there are increased numbers of CD163+ CD204+ CD206+ M2 alveolar macrophages in stage III/IV COPD patients, and MMP-9 positive alveolar macrophages, presumably M2 macrophages, were increased in the lungs of very severe COPD. Here, CD163 is linked to chronic obstructive pulmonary disease.